Protein,Protein_definition,Disease_category,Disease,method,nsnp,OR [95% CI],Pvalue,QTL_type
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CHRONKIDNEYDIS,Wald ratio,1,1.34 [1.24-1.45],5.28535483848273e-14,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CARDARR,Inverse variance weighted,2,1.09 [1.04-1.15],0.000717312630179103,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_IMPLICIT,Wald ratio,1,0.69 [0.54-0.9],0.00550595636107353,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_PAD,Inverse variance weighted,2,1.11 [1.02-1.2],0.011286213959293,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NOCOMP,Inverse variance weighted,69,1.03 [1.01-1.06],0.013836798979404,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2PERIPH,Wald ratio,1,1.07 [1.01-1.13],0.0147552113427276,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2NEU,Wald ratio,1,1.07 [1.01-1.13],0.0161427875180516,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_NSTEMI,Inverse variance weighted,4,1.08 [1.01-1.15],0.0310692298870991,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_ATHSCLE,Inverse variance weighted,13,1.08 [1.01-1.15],0.0316274624948462,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_RENALTUB,Wald ratio,1,0.71 [0.52-0.97],0.0337045582499438,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_BACTERIAL,Wald ratio,1,0.78 [0.61-0.99],0.0395361174340744,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM2REN,Inverse variance weighted,5,1.05 [1-1.1],0.0723412853215591,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_GOUT,Inverse variance weighted,24,0.98 [0.96-1],0.103456631864927,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_K_CARDIAC,Inverse variance weighted,2,1.12 [0.98-1.28],0.103937423525672,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_URETHRAOTH,Inverse variance weighted,5,0.88 [0.75-1.03],0.112247994419299,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,GOUT_NOS,Inverse variance weighted,14,0.98 [0.96-1.01],0.121525903291972,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_DIAHER,Inverse variance weighted,8,0.96 [0.92-1.01],0.123093824882386,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_LOWCHRON,Inverse variance weighted,61,0.96 [0.91-1.01],0.126445601627133,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_INTESTOTH,Inverse variance weighted,10,1.1 [0.97-1.24],0.150582021025042,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_POLYARTHROPATHIES,Inverse variance weighted,16,0.95 [0.89-1.02],0.154973549239157,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_GASTRODUOULC,Inverse variance weighted,4,1.15 [0.94-1.41],0.17475481162724,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,COLITNONINFNAS,Wald ratio,1,1.16 [0.93-1.44],0.179030338010795,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_MINERAL_MET,Wald ratio,1,0.96 [0.91-1.02],0.183801481817275,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_CALCUKIDUR,Inverse variance weighted,26,1.03 [0.99-1.08],0.187098518107516,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,M13_RHEUMA,Inverse variance weighted,22,1.02 [0.99-1.07],0.211639309720733,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_GLUCOPANCREAS,Wald ratio,1,0.95 [0.87-1.03],0.230755190426668,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_BLOOD_IMMUN,Wald ratio,1,1.21 [0.88-1.67],0.239597622411976,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_ASTHMA_EXMORE,Inverse variance weighted,59,0.97 [0.93-1.02],0.257130217829457,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_OTHER_SEPSIS,Wald ratio,1,1.11 [0.92-1.34],0.284368473723368,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_PARATHYRO,Inverse variance weighted,10,1.04 [0.97-1.11],0.291694015468862,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERPARA,Inverse variance weighted,10,1.03 [0.97-1.1],0.302930774007285,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_LBBB,Inverse variance weighted,2,1.03 [0.97-1.08],0.32709820769134,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_OTHERANAEMIA,Wald ratio,1,1.11 [0.89-1.39],0.344518687614878,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_NOS,Inverse variance weighted,6,0.98 [0.94-1.02],0.352885917108765,trans
SCG2,Secretogranin-2,Chapter VI Diseases of the nervous system,G6_POLYOTHUNS,Inverse variance weighted,2,0.94 [0.82-1.07],0.359030092321575,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_LOWERINF,Wald ratio,1,0.89 [0.7-1.15],0.374282382629059,trans
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_BCKGRND_RETINA,Inverse variance weighted,3,1.03 [0.96-1.1],0.387246356347297,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,CHRONNAS,Inverse variance weighted,9,0.99 [0.96-1.02],0.394549975790471,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OESSTODUO,Wald ratio,1,1.2 [0.78-1.85],0.397004454312931,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_INFLUPNEU,Inverse variance weighted,3,1.09 [0.88-1.36],0.41111527838502,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIANAS,Inverse variance weighted,4,0.95 [0.83-1.08],0.418428414758064,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_LIVER,Inverse variance weighted,8,0.98 [0.92-1.04],0.428661194006699,trans
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_INFECT_SKIN,Wald ratio,1,0.89 [0.66-1.2],0.446676854268158,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_RESPIRATORY,Inverse variance weighted,15,0.96 [0.86-1.07],0.464588887814644,trans
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CATARACTOTHER,Inverse variance weighted,12,1.02 [0.96-1.08],0.490659201599527,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_FLUIDELECTRO,Wald ratio,1,1.06 [0.9-1.24],0.495947838587889,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPOOSMNAT,Wald ratio,1,1.04 [0.93-1.16],0.495947838587889,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_HYPERLIPNAS,Inverse variance weighted,21,0.98 [0.92-1.04],0.532714183333218,trans
SCG2,Secretogranin-2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,D3_ANAEMIA_IRONDEF_NAS,Inverse variance weighted,7,0.97 [0.9-1.06],0.534874716083361,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,Wald ratio,1,0.97 [0.87-1.08],0.541509908056798,trans
SCG2,Secretogranin-2,Chapter VI Diseases of the nervous system,G6_PARKINSON,Inverse variance weighted,3,0.98 [0.93-1.04],0.562337692002757,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_GASTROENTERITIS_NOS,Inverse variance weighted,2,0.73 [0.24-2.17],0.565827968070574,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ENDOGLAND,Inverse variance weighted,2,0.94 [0.74-1.18],0.578599345119253,trans
SCG2,Secretogranin-2,Chapter XIV Diseases of the genitourinary system,N14_DIALYSIS,Inverse variance weighted,4,0.97 [0.86-1.1],0.631298992073564,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_ENERCOLNONINF,Inverse variance weighted,35,0.99 [0.96-1.03],0.648437990185157,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_ACUTELOWERNAS,Wald ratio,1,0.97 [0.87-1.1],0.671562759040749,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CONDUCTIO,Inverse variance weighted,4,1.02 [0.94-1.1],0.68637561065145,trans
SCG2,Secretogranin-2,Chapter I Certain infectious and parasitic diseases,AB1_SEPSIS_CONDITION,Wald ratio,1,1.07 [0.77-1.48],0.686423974412764,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_ACIDOSIS,Wald ratio,1,0.99 [0.96-1.03],0.698586855315883,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEPHROPATHY_EXMORE,Inverse variance weighted,5,1.01 [0.95-1.09],0.699023902959544,trans
SCG2,Secretogranin-2,Chapter XII Diseases of the skin and subcutaneous tissue,L12_DECUBITANSULCERANDPRESSURE,Wald ratio,1,0.99 [0.92-1.06],0.730649921332041,trans
SCG2,Secretogranin-2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,RHEUMA_OTHER_WIDE,Inverse variance weighted,5,1.01 [0.94-1.08],0.773130279392297,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_CD_STRICT2,Inverse variance weighted,8,1 [0.97-1.02],0.776200890693175,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_CROHN,Inverse variance weighted,3,1 [0.96-1.05],0.817741643571878,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,ASTHMA_NAS,Inverse variance weighted,13,0.99 [0.93-1.06],0.840919421686218,trans
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",H7_CHOROIDRETINA,Inverse variance weighted,9,1.01 [0.95-1.07],0.847703980026701,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_CD_NOUC,Inverse variance weighted,4,1 [0.97-1.03],0.873679647305192,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_CARDMYO,Inverse variance weighted,18,1 [0.98-1.02],0.924465045152268,trans
SCG2,Secretogranin-2,Chapter IX Diseases of the circulatory system,I9_HEARTFAIL,Inverse variance weighted,4,1 [0.89-1.11],0.93273622847713,trans
SCG2,Secretogranin-2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",DM_MACULOPATHY_EXMORE,Inverse variance weighted,8,1 [0.95-1.05],0.946690599576814,trans
SCG2,Secretogranin-2,"Chapter IV Endocrine, nutritional and metabolic diseases",E4_DM1NOCOMP,Inverse variance weighted,3,1 [0.93-1.08],0.948179002073676,trans
SCG2,Secretogranin-2,Chapter X Diseases of the respiratory system,J10_PNEUMONAS,Wald ratio,1,1 [0.79-1.26],0.979651843347748,trans
SCG2,Secretogranin-2,Chapter XI Diseases of the digestive system,K11_OTHENTERCOL,Inverse variance weighted,2,1 [0.8-1.24],0.991736319055743,trans
